AllSquare Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.4K | Hold |
153
| – | – | 0.01% | 314 |
|
|
2025
Q2 | $19.2K | Hold |
153
| – | – | 0.01% | 322 |
|
|
2025
Q1 | $20.9K | Buy |
153
+120
| +364% | +$17.2K | 0.01% | 302 |
|
|
2024
Q4 | $5.05K | Hold |
33
| – | – | ﹤0.01% | 433 |
|
|
2024
Q3 | $6.4K | Hold |
33
| – | – | ﹤0.01% | 416 |
|
|
2024
Q2 | $7.65K | Hold |
33
| – | – | ﹤0.01% | 396 |
|
|
2024
Q1 | $7.12K | Hold |
33
| – | – | ﹤0.01% | 402 |
|
|
2023
Q4 | $8.54K | Hold |
33
| – | – | 0.01% | 386 |
|
|
2023
Q3 | $8.48K | Hold |
33
| – | – | 0.01% | 383 |
|
|
2023
Q2 | $9.86K | Hold |
33
| – | – | 0.01% | 375 |
|
|
2023
Q1 | $9.18K | Hold |
33
| – | – | 0.01% | 383 |
|
|
2022
Q4 | $9.14K | Hold |
33
| – | – | 0.01% | 371 |
|
|
2022
Q3 | $9K | Hold |
33
| – | – | 0.01% | 364 |
|
|
2022
Q2 | $7K | Hold |
33
| – | – | ﹤0.01% | 397 |
|
|
2022
Q1 | $7K | Hold |
33
| – | – | ﹤0.01% | 401 |
|
|
2021
Q4 | $8K | Hold |
33
| – | – | ﹤0.01% | 394 |
|
|
2021
Q3 | $9K | Hold |
33
| – | – | 0.01% | 375 |
|
|
2021
Q2 | $11K | Hold |
33
| – | – | 0.01% | 377 |
|
|
2021
Q1 | $9K | Hold |
33
| – | – | 0.01% | 389 |
|
|
2020
Q4 | $8K | Hold |
33
| – | – | 0.01% | 363 |
|
|
2020
Q3 | $9K | Hold |
33
| – | – | 0.01% | 340 |
|
|
2020
Q2 | $9K | Hold |
33
| – | – | 0.01% | 345 |
|
|
2020
Q1 | $10K | Hold |
33
| – | – | 0.01% | 303 |
|
|
2019
Q4 | $10K | Hold |
33
| – | – | 0.01% | 323 |
|
|
2019
Q3 | $8K | Hold |
33
| – | – | 0.01% | 338 |
|
|
2019
Q2 | $8K | Hold |
33
| – | – | 0.01% | 350 |
|
|
2019
Q1 | $8K | Hold |
33
| – | – | 0.01% | 349 |
|
|
2018
Q4 | $10K | Hold |
33
| – | – | 0.01% | 306 |
|
|
2018
Q3 | $12K | Hold |
33
| – | – | 0.01% | 321 |
|
|
2018
Q2 | $10K | Buy |
+33
| New | +$9.28K | 0.01% | 337 |
|
|
2017
Q1 | – | Sell |
-22
| Closed | -$6K | – | 370 |
|
|
2016
Q4 | $6K | Sell |
22
-10
| -31% | -$2.96K | 0.01% | 260 |
|
|
2016
Q3 | $10K | Sell |
32
-77
| -71% | -$22.8K | 0.01% | 215 |
|
|
2016
Q2 | $26K | Sell |
109
-25
| -19% | -$6.59K | 0.03% | 151 |
|
|
2016
Q1 | $35K | Buy |
134
+18
| +16% | +$4.75K | 0.03% | 134 |
|
|
2015
Q4 | $36K | Buy |
116
+28
| +32% | +$8.05K | 0.04% | 133 |
|
|
2015
Q3 | $26K | Hold |
88
| – | – | 0.03% | 149 |
|
|
2015
Q2 | $36K | Buy |
88
+47
| +115% | +$18.9K | 0.03% | 138 |
|
|
2015
Q1 | $17K | Buy |
41
+15
| +58% | +$5.91K | 0.02% | 187 |
|
|
2014
Q4 | $9K | Buy |
+26
| New | +$8.41K | 0.01% | 236 |
|
Other funds holding BIIB
AllSquare Wealth Management's BIIB Position: Q3 2025 in Review
AllSquare Wealth Management held its Biogen (BIIB) position steady in Q3 2025 at 153 shares worth $21.4K. The position accounts for 0.01% of the portfolio, ranked #314.
AllSquare Wealth Management first reported a position in BIIB in Q4 2014 and has held it in 39 quarters since. The position peaked at $36K in Q4 2015. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- AllSquare Wealth Management held 153 shares of Biogen worth $21.4K as of Q3 2025.
- AllSquare Wealth Management left its Biogen share count unchanged in Q3 2025.
- Biogen made up 0.01% of AllSquare Wealth Management's portfolio in Q3 2025, its #314 holding.
- AllSquare Wealth Management first reported a position in Biogen in Q4 2014 and has held it in 39 quarters since.
- AllSquare Wealth Management's Biogen position peaked at $36K in Q4 2015.
- 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.